Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 8, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • SGL: Hidden part in Bacteriophages could be a Protein Antibiotic

Graphene Nano-particles: Interrupts anxiety-related behaviour

NABI Research Associate & JRF Jobs With Rs. 47,000 pm Salary

SGL: Hidden part in Bacteriophages could be a Protein Antibiotic
  • BiotechToday
  • World

SGL: Hidden part in Bacteriophages could be a Protein Antibiotic

bioxone March 18, 2021March 18, 2021

Ayooshi Mitra, Amity University, Kolkata

Antibiotic-resistant bacteria are becoming a greater threat to human health day by day, necessitating the development of new antibiotics. Bacteriophages and their potential as antibacterial agents to combat pathogenic bacteria have sparked renewed interest. This is largely due to the phage’s ability to cause a cellular breakdown in the bacterial host via its ‘lysis genes.’ Most phages can rupture their host cell, a process known as lysis, wherein they release new phage virions known as “progeny” that are genetically and structurally identical to the parent virus.

Small phages produce a single protein that causes host lysis. Essentially, the virus produces a protein antibiotic that causes lysis in the same way that antibiotics like penicillin do – by interfering with the multistage process of cell wall biosynthesis. When an infected cell attempts to divide, it explodes because it is unable to form a new cell wall between the daughter cells. In a recent study conducted by researchers of Texas A&M University, it is said that the researchers believe that these small lysis proteins could serve as a model for a whole new class of antibiotics. The research points to the lysis of leviviruses, which are bacteriophages with single-stranded RNA genomes having three to four genes. There have been tens of thousands of leviviruses discovered. Sgl, which stands for “single gene lysis,” is one of the known levivirus genes. Sgl is a gene that produces a protein that causes bacteria to break down their cells. Sgl genes are found in many leviviruses, but they have remained “hidden” from researchers because they are small, diverse, and can be embedded within other genes.

The researchers said in an interview, that they wanted to discover these “hidden” genes and understand their structure and evolution so they can understand how these will be able to benefit the development of novel antibiotics. the researchers could recognise 35 different Sgls that had lytic or negative effects on E. coli bacteria. The researchers also discovered that each of these Sgls could represent a different mechanism for the lysis of host cells. According to previous research, single-stranded RNA phages have high mutation rates. These phages can infect new bacteria species thanks to their high mutation rates. The phages must either change the existing Sgl gene or evolve a new Sgl to escape the new hosts. Even though genomic RNA has a very short total length, these phages can encode two or more Sgls or proto-Sgls for lytic activity against multiple bacterial hosts.

The discovery that a large proportion of the Sgls found in the study originated and evolved within the gene for the phage replication protein, or Rep, was another far-reaching aspect of the research. Finally, according to the findings, Sgls are extremely diverse and have yet to be fully exploited as a source of peptides that could be used in protein antibiotics to attack bacteria’s cellular function. The researchers hope that their findings will aid in the discovery of small genes and their biological functions in RNA viruses found in more complex organisms like plants and animals and provide a model for studying the evolution of new genes.

Also read:An E-textile that controls biological energy when worn

Reference:

  1. “Rapid de novo evolution of lysis genes in single-stranded RNA phages” by Karthik R. Chamakura, Jennifer S. Tran, Chandler O’Leary, Hannah G. Lisciandro, Sophia F. Antillon, Kameron D. Garza, Elizabeth Tran, Lorna Min and Ry Young, 26 November 2020, Nature Communications.DOI: 10.1038/s41467-020-19860-0
  2. https://scitechdaily.com/hidden-genes-in-bacteriophages-could-be-key-in-development-of-new-antibiotics/amp/
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged antibacterial agent antibiotic-resistant antibiotics bacteria bacteriophage biosynthesis cellular breakdown host cell levivirus lysis RNA RNA virus SGL virion

One thought on “SGL: Hidden part in Bacteriophages could be a Protein Antibiotic”

  1. Pingback: Phantom Limb Pain - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

NABI Research Associate & JRF Jobs With Rs. 47,000 pm Salary

bioxone March 18, 2021

-Shristi Sharma, Team bioXone NABI Vacancies – JRF & Research Associate Posts Available. National Agri-Food Biotechnology Institute (NABI) is hiring for research positions. NABI job opportunity details, project details, application procedure details given below: National Agri-Food Biotechnology Institute (NABI) (Dept. of Biotechnology, Govt. of India) Sector-81, Knowledge City, Mohali P.O, S.A.S. Nagar-140306, Punjab, India. Website: […]

Related Post

  • BiotechToday
  • World

ODM-207 – First-in-human Phase 1 study of BET inhibitor for solid tumour patients

bioxone October 1, 2020October 1, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA BET (Bromodomain and extra terminal domain) proteins are described to be epigenetic and anti-cancer drug targets. This was the first-in-human study that judged the pharmacokinetics and prior activity of ODM-20, the inhibitor of BET in patients having solid tumours.  The main objective was to determine the tolerability, dose-limiting toxicities (DLT), […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Myocardial injury in severe COVID 19 as compared to non-COVID ARDS

bioxone November 20, 2020November 20, 2020

Rohit Bhattacharjee, Amity University Kolkata Cardiac troponin elevations in COVID 19 are common in myocardial injuries, also proposed as a prognostic factor. Important knowledge gaps remain in comprehending the clinical implications and epidemiology of myocardial injury. It is also not clear whether the incidence of myocardial injury in COVID-19 patients is higher than that observed […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

COMMON SEASONAL CORONAVIRUSES DOESN’T OFFER ANY PROTECTION-FIND OUT!

bioxone November 22, 2020November 22, 2020

AISHILA KAR, AMITY UNIVERSITY KOLKATA Severe respiratory problem coronavirus 2 (SARS-CoV-2) has fastly spread within the human population. In spite of the fact, SARS-CoV-2 is a novel coronavirus, most humans had been early exposed to other antigenically different common seasonal human coronaviruses (hCoVs) earlier than the COVID-19 pandemic. Few scientists have suggested that people might […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy